Collaboration - May 11, 2015
Recipharm, LIDDS Talk Collaboration
Recipharm has begun negotiations with the pharmaceutical company LIDDS about collaborating on making Liproca Depot® ahead of continued clinical development and a potential future market launch. The companies explained in a joint letter their intention to initiate collaboration in the areas of scale-up, manufacture and quality assurance of LIDDS’ pharmaceutical products. Initially the companies will […]
Clinical Trials - April 20, 2015
Active Biotech Shares Plunge
Shares of Ipsen and partner Active Biotech plunged last week after Ipsen’s experimental prostate cancer drug Tasquinimod failed during a Phase III trial. Active’s shares dropped 60 percent and Ipsen’s went down by 10 percent. “The data at hand is unambiguous and cannot motivate further development of tasquinimod in this patient population,” said Tomas Leanderson, […]
